| Year |
Citation |
Score |
| 2021 |
Huang HC, Sung YC, Li CP, Wan D, Chao PH, Tseng YT, Liao BW, Cheng HT, Hsu FF, Huang CC, Chen YT, Liao YH, Hsieh HT, Shih YC, Liu IJ, et al. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours. Gut. PMID 34921062 DOI: 10.1136/gutjnl-2021-325180 |
0.648 |
|
| 2021 |
Vogler J, Böttger R, Fayez NAL, Zhang W, Qin Z, Hohenwarter L, Chao PH, Rouhollahi E, Bilal N, Chen N, Lee B, Chen C, Wilkinson B, Kieffer TJ, Kulkarni JA, et al. Altering the intra-liver distribution of phospholipid-free small unilamellar vesicles using temperature-dependent size-tunability. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33771624 DOI: 10.1016/j.jconrel.2021.03.025 |
0.388 |
|
| 2020 |
Böttger R, Pauli G, Chao PH, Al-Fayez N, Hohenwarter L, Li SD. Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews. PMID 32574575 DOI: 10.1016/J.Addr.2020.06.017 |
0.563 |
|
| 2018 |
Sung YC, Liu YC, Chao PH, Chang CC, Jin PR, Lin TT, Lin JA, Cheng HT, Wang J, Lai CP, Chen LH, Wu AY, Ho TL, Chiang T, Gao DY, et al. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development. Theranostics. 8: 894-905. PMID 29463989 DOI: 10.7150/Thno.21168 |
0.369 |
|
| 2017 |
Chih-Chun C, Yang Y, Gao DY, Cheng HT, Hoang B, Chao PH, Chen LH, Bteich J, Chiang T, Liu JY, Li SD, Chen Y. Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in Mice. Journal of Drug Targeting. 1-27. PMID 29251522 DOI: 10.1080/1061186X.2017.1419358 |
0.718 |
|
| Show low-probability matches. |